Incisionless MR-guided focused ultrasound: technical considerations and current therapeutic approaches in psychiatric disorders. (2nd July 2020)

• Record Type: Journal Article
• Authors: Kinfe, Thomas; Stadlbauer, Andreas; Winder, Klemens; Hurlemann, Rene; Buchfelder, Michael
• Is Part Of: Expert review of neurotherapeutics. Volume 20:Number 7(2020)
• Page Start: 687
• Page End: 696
• Publication Date: 2020-07-02
• Subjects: Noninvasive MR-guided focused ultrasound -- cingulotomy -- capsulotomy -- deep brain stimulation -- depression -- obsessive-compulsive disorder -- radiosurgery -- outcome measures; Neuropharmacology -- Periodicals; 615.7805
• DOI: 10.1080/14737175.2020.1779590
• Languages: English
• ISSNs: 1473-7175

Abstract

ABSTRACT: Introduction: MR-guided focused ultrasound operating at higher intensities have been reported to effectively and precisely ablate deeper brain structures like the basal ganglia or the thalamic nuclei for the treatment of refractory movement disorders, neuropathic pain and most recently neuropsychiatric disorders, while low-intensity focused ultrasound represents an approach promoting mechanical blood-brain-barrier opening and neuromodulation. This narrative review summarizes the technical development and the therapeutic potential of incisionless MRgFUS in order to treat neuropsychiatric disorders. Areas covered: A narrative review of clinical trials assessing the safety and efficacy of MRgFUS. A literature review was performed using the following search terms: MR-guided focused ultrasound, psychiatric disorders, noninvasive and invasive brain modulation/stimulation techniques. Expert opinion: MRgFUS ablation is under clinical investigation (unblinded study design) for obsessive-compulsive disorders (OCDs) [capsulotomy; ALIC] and depression/anxiety disorders [capsulotomy] and has demonstrated an improvement in OCD and depression, although of preliminary character. Low-intensity ultrasound applications have been explored in Alzheimer´s disease (phase 1 study) and healthy subjects. Currently, limited evidence hinders comparison and selection between MRgFUS and noninvasive/invasive brain modulation therapies. However, comparative, sham-controlled trials are needed to reexamine the preliminary findings for the treatment of psychiatric disorders.